KTMED, The Republic of Korea - Komachine Supplier Profile and Product List

- KTMED Co., Ltd. is a specialized venture company in bio-signal measuring devices, established in 2000. The company primarily develops and manufactures portable mesh nebulizers and patient monitors based on advanced nanotechnology. It is a company supplying various medical devices to domestic and international hospitals and individual consumers. KTMED is growing into a comprehensive medical device company encompassing drug delivery systems and bio-signal measurement technologies.KTMED Co., Ltd. is a specialized venture company in bio-signal measuring devices, established in 2000. The company primarily develops and manufactures portable mesh nebulizers and patient monitors based on advanced nanotechnology. It is a company supplying various medical devices to domestic and international hospitals and individual consumers. KTMED is growing into a comprehensive medical device company encompassing drug delivery systems and bio-signal measurement technologies.
- The company holds mesh nebulizer product lines including NE-SM1 (NePlus), NE-SM3 (K-NEB), and K-NEB II models. Its advanced nanotechnology-based vibrating mesh technology features nearly silent, ultra-compact, and lightweight designs. The devices allow 2 hours of continuous use with a mobile phone charger, along with technology to minimize drug residue. Specifications include a nebulization rate of approximately 0.25ml/min and an average particle size of 5μm MMAD.The company holds mesh nebulizer product lines including NE-SM1 (NePlus), NE-SM3 (K-NEB), and K-NEB II models. Its advanced nanotechnology-based vibrating mesh technology features nearly silent, ultra-compact, and lightweight designs. The devices allow 2 hours of continuous use with a mobile phone charger, along with technology to minimize drug residue. Specifications include a nebulization rate of approximately 0.25ml/min and an average particle size of 5μm MMAD.
- Patient monitor product lines offer KTPM-10X0 series, EPOX (KTPE-01), and ANGELUS models. These devices provide measurement functions for 6 parameters, including ECG, respiration, SpO2, NIBP, CO2, and temperature. Modular design technology allows flexible adaptation to hospital environments. Features include ESU protection, defibrillator protection, lightweight, and compact design suitable for various medical settings.Patient monitor product lines offer KTPM-10X0 series, EPOX (KTPE-01), and ANGELUS models. These devices provide measurement functions for 6 parameters, including ECG, respiration, SpO2, NIBP, CO2, and temperature. Modular design technology allows flexible adaptation to hospital environments. Features include ESU protection, defibrillator protection, lightweight, and compact design suitable for various medical settings.
- The OXYPALM pulse oximeter boasts a compact design and 40 hours of portable use. It offers 72 hours of data storage and analysis capabilities through OXYVIEW software. The company possesses capabilities in developing and supplying SpO2 sensors and OEM products.The OXYPALM pulse oximeter boasts a compact design and 40 hours of portable use. It offers 72 hours of data storage and analysis capabilities through OXYVIEW software. The company possesses capabilities in developing and supplying SpO2 sensors and OEM products.
- Development of the 'E2-KIT' (E-Square Kit), an educational equipment for engineering students to practice bio-signal processing.Development of the 'E2-KIT' (E-Square Kit), an educational equipment for engineering students to practice bio-signal processing.
- Over 20 years of experience in bio-signal device technology and top-tier domestic technical expertise.Over 20 years of experience in bio-signal device technology and top-tier domestic technical expertise.
- Pioneering development of advanced nanotechnology-based vibrating mesh nebulizers in Korea, recognized as world-class products.Pioneering development of advanced nanotechnology-based vibrating mesh nebulizers in Korea, recognized as world-class products.
- Securing a differentiated competitive advantage with ultra-compact, silent products that resolve the noise and portability issues of conventional nebulizers.Securing a differentiated competitive advantage with ultra-compact, silent products that resolve the noise and portability issues of conventional nebulizers.
- In the patient monitor sector, the company demonstrates technical prowess through modular designs, flexibly responding to hospital requirements.In the patient monitor sector, the company demonstrates technical prowess through modular designs, flexibly responding to hospital requirements.
- Product utility and safety validated through clinical trials at Seoul Asan Hospital and publication in European academic journals.Product utility and safety validated through clinical trials at Seoul Asan Hospital and publication in European academic journals.
- High reliability achieved through international quality and product certifications, including ISO 9000, ISO 13485, and CE Mark.High reliability achieved through international quality and product certifications, including ISO 9000, ISO 13485, and CE Mark.
- Continuous investment in R&D and ownership of 15 patents, expanding its technology portfolio and strengthening expertise.Continuous investment in R&D and ownership of 15 patents, expanding its technology portfolio and strengthening expertise.
- Annual participation in international exhibitions such as MEDICA in Germany and ARAB HEALTH in Dubai, earning favorable reviews in the global market.Annual participation in international exhibitions such as MEDICA in Germany and ARAB HEALTH in Dubai, earning favorable reviews in the global market.
- Medical institutions (general hospitals, emergency rooms, intensive care units, operating rooms).Medical institutions (general hospitals, emergency rooms, intensive care units, operating rooms).
- Emergency medical services (ambulances and on-site emergency situations).Emergency medical services (ambulances and on-site emergency situations).
- Home healthcare (personal consumers and self-diagnosis through portable nebulizers and pulse oximeters).Home healthcare (personal consumers and self-diagnosis through portable nebulizers and pulse oximeters).
- Veterinary medicine (supply of patient monitors and pulse oximeters for animal hospitals).Veterinary medicine (supply of patient monitors and pulse oximeters for animal hospitals).
- Education and research (supply of bio-signal processing practical training equipment to engineering universities and research institutes).Education and research (supply of bio-signal processing practical training equipment to engineering universities and research institutes).
- South Korea, Japan, China, Middle EastSouth Korea, Japan, China, Middle East
- Germany, across EuropeGermany, across Europe
- AmericasAmericas
- South AmericaSouth America
- Acquisition of ISO 9000 quality management system certification.Acquisition of ISO 9000 quality management system certification.
- Acquisition of ISO 13485 medical device quality management system certification.Acquisition of ISO 13485 medical device quality management system certification.
- Attainment of CE Mark (European certification standard) for products.Attainment of CE Mark (European certification standard) for products.
- Possession of a total of 15 patents.Possession of a total of 15 patents.
- Holding patent certificates, design registration certificates, and trademark registration certificates related to NEPLUS.Holding patent certificates, design registration certificates, and trademark registration certificates related to NEPLUS.
- Plans for obtaining FDA and various other certification marks for entry into the American market.Plans for obtaining FDA and various other certification marks for entry into the American market.
- Establishment of a corporate research institute by the Korea Industrial Technology Association in 2001.Establishment of a corporate research institute by the Korea Industrial Technology Association in 2001.
- Securing 11 project-based patents through the execution of government R&D projects.Securing 11 project-based patents through the execution of government R&D projects.